1993
DOI: 10.1007/bf02244932
|View full text |Cite
|
Sign up to set email alerts
|

Voluntary consumption of morphine in 15 inbred mouse strains

Abstract: To determine genetic differences in voluntary morphine consumption, 15 commonly used inbred strains of mice were given ad libitum two-bottle choice between saccharin alone or saccharin/morphine in one bottle and water in the other bottle. Subsequently, the saccharin was gradually reduced to zero, leaving only morphine. Independent groups of mice of the same strains were exposed to quinine in a parallel manner to control for the bitter alkaloid taste of morphine. Of the 15 strains, the C57BL/6J strain showed th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

15
91
0
1

Year Published

1995
1995
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 95 publications
(107 citation statements)
references
References 17 publications
15
91
0
1
Order By: Relevance
“…Since then, a number of laboratories have pursued studies of this mouse model. Confirmation of the strain difference between B6 and D2 mice in oral morphine preference (Belknap, 1990;Belknap et al, 1993) was followed by a quantitative genetic study that mapped a major locus for the trait to chromosome 10 (Berrettini et al, 1994b). This QTL for oral morphine preference, termed Mop2, was confirmed in a follow-up study (Alexander et al, 1996) and support was generated for the concept that it had a broader influence with regard to the pharmacological effects of morphine being involved also in determining morphine-induced analgesia and the density of [ 3 H]naloxone binding sites in the brain (Belknap et al, 1995).…”
Section: Discussionsupporting
confidence: 45%
See 1 more Smart Citation
“…Since then, a number of laboratories have pursued studies of this mouse model. Confirmation of the strain difference between B6 and D2 mice in oral morphine preference (Belknap, 1990;Belknap et al, 1993) was followed by a quantitative genetic study that mapped a major locus for the trait to chromosome 10 (Berrettini et al, 1994b). This QTL for oral morphine preference, termed Mop2, was confirmed in a follow-up study (Alexander et al, 1996) and support was generated for the concept that it had a broader influence with regard to the pharmacological effects of morphine being involved also in determining morphine-induced analgesia and the density of [ 3 H]naloxone binding sites in the brain (Belknap et al, 1995).…”
Section: Discussionsupporting
confidence: 45%
“…Compared to other inbred strains, C57BL/6 (B6) mice voluntarily drink large quantities of sweetened morphine solutions (Horowitz et al, 1977;Belknap et al, 1993). Oral morphine intake by B6 mice is attenuated following treatment with opioid antagonists (Berrettini et al, 1994a) suggesting that consumption of morphine solutions elicits opioid receptor-mediated phenomena in the brain.…”
Section: Introductionmentioning
confidence: 99%
“…Human family studies demonstrate that addiction's vulnerability is influenced both by genes and environmental conditions (Uhl, 1999;True et a., 1999;Vanyukov & Tarter, 2000). Similarly, individual vulnerability to drug abuse in animal models depends on both genetic Belknap et al, 1993a, 1993b, Meliska et al, 1995 and environmental risk factors for addiction (Bowling et al, 1993;Bowling & Bardo, 1994;Cabib et al, 2000;de Jong & Kloet, 2004;Nader & Czoty, 2005).…”
Section: Individual Vulnerabilitysupporting
confidence: 42%
“…Given this fact, various animal models of substance abuse and dependence have been developed and are being used to identify genes involved in these disorders. To identify genes involved in substance abuse, we have used a common mouse model in which two mouse strains, C57BL/6J (B6) and DBA/2J (D2), differ in the expression of behaviors related to substances of abuse, including alcohol (Belknap et al, 1993b) and opiates (Belknap et al, 1993a). With respect to opiates, particularly morphine, B6 and D2 mice differ in voluntary intake (either by consumption of morphine-containing liquid or food, or by operant intravenous self administration) (Horowitz et al, 1977;Belknap et al, 1993a;Suzuki et al, 1991;Elmer GI, personal communication), development of tolerance (Frigeni et al, 1981) and dependence (Belknap, 1990;Suzuki et al, 1991), withdrawal symptoms (Suzuki et al, 1991;Kest et al, 2002), analgesia (Belknap et al, 1995), antinociception (Bergeson et al, 2001), Straub tail (Belknap, 1990), hypothermia (Muraki and Kato, 1987), and reward as determined by conditioned place preference (Cunningham et al, 1992;Orsini et al, 2005).…”
Section: Introductionmentioning
confidence: 45%